Live feed
Filing
SC 13G
SC 13G0000902219-23-000002·Syndax Pharmaceuticals Inc
Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2022-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,983,442
- Percent of class
- 11.7200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-23-000002
- Form type
- SC 13G
- Filer
- Syndax Pharmaceuticals Inc
- CIK
- CIK 1395937
- Filed
- Jan 10, 2023
- Reporting period
- Dec 30, 2022
- Description
- Schedule 13G beneficial ownership